Single‐cell RNA sequencing reveals tumor heterogeneity, microenvironment, and drug‐resistance mechanisms of recurrent glioblastoma

Overexpression of SKA Complex Is Associated With Poor Prognosis in Gliomas

(2022) Shoukai Yu   Frontiers in Neurology

Single-cell landscapes of primary glioblastomas and matched explants and cell lines show variable retention of inter- and intratumor heterogeneity

(2022) Véronique G. LeBlanc et al.   CANCER CELL

Interrogating glioma-M2 macrophage interactions identifies Gal-9/Tim-3 as a viable target against PTEN -null glioblastoma

(2022) Xiangrong Ni et al.   Science Advances

The Many Facets of Therapy Resistance and Tumor Recurrence in Glioblastoma

(2021) Anshika Goenka et al.   Cells

Identification of Hub Genes and Key Pathways Associated with Anti-VEGF Resistant Glioblastoma Using Gene Expression Data Analysis

(2021) Kesavan R. Arya et al.   Biomolecules

Single-cell profiling of myeloid cells in glioblastoma across species and disease stage reveals macrophage competition and specialization

(2021) Ana Rita Pombo Antunes et al.   NATURE NEUROSCIENCE

Macrophages/Microglia in the Glioblastoma Tumor Microenvironment

(2021) Jun Ma et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Single-cell multimodal glioma analyses identify epigenetic regulators of cellular plasticity and environmental stress response

(2021) Kevin C. Johnson et al.   NATURE GENETICS

Genotoxic therapy and resistance mechanism in gliomas

(2021) Fengchao Lang et al.   PHARMACOLOGY & THERAPEUTICS

Single-Cell Atlas Reveals Complexity of the Immunosuppressive Microenvironment of Initial and Recurrent Glioblastoma

(2020) Weilun Fu et al.   Frontiers in Immunology

Bevacizumab dose adjustment to improve clinical outcomes of glioblastoma

(2020) N. García-Romero et al.   BMC Medicine

MGMT genomic rearrangements contribute to chemotherapy resistance in gliomas

(2020) Barbara Oldrini et al.   Nature Communications

Primary mismatch repair deficient IDH-mutant astrocytoma (PMMRDIA) is a distinct type with a poor prognosis

(2020) Abigail K. Suwala et al.   ACTA NEUROPATHOLOGICA

Identification of diverse tumor endothelial cell populations in malignant glioma

(2020) Jeff C Carlson et al.   NEURO-ONCOLOGY

Current State of Immunotherapy for Treatment of Glioblastoma

(2019) Tresa McGranahan et al.   CURRENT TREATMENT OPTIONS IN ONCOLOGY

Global, regional, and national burden of brain and other CNS cancer, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

(2019) Anoop P Patel et al.   LANCET NEUROLOGY

Pathological and Molecular Features of Glioblastoma and Its Peritumoral Tissue

(2019) Alessio D’Alessio et al.   Cancers

Fast, sensitive and accurate integration of single-cell data with Harmony

(2019) Ilya Korsunsky et al.   NATURE METHODS

OUP accepted manuscript

(2018)   BIOINFORMATICS

PRL-3 is a potential glioblastoma prognostic marker and promotes glioblastoma progression by enhancing MMP7 through the ERK and JNK pathways

(2018) Nan Mu et al.   Theranostics

A novel enhancer regulates MGMT expression and promotes temozolomide resistance in glioblastoma

(2018) Xiaoyue Chen et al.   Nature Communications

Chemoresistance caused by the microenvironment of glioblastoma and the corresponding solutions

(2018) Xin Zhang et al.   BIOMEDICINE & PHARMACOTHERAPY

Epidemiology and Overview of Gliomas

(2018) Mary Elizabeth Davis   Seminars in Oncology Nursing

Sulfated polysaccharide JCS1S2 inhibits angiogenesis via targeting VEGFR2/VEGF and blocking VEGFR2/Erk/VEGF signaling

(2018) Zheng Wang et al.   CARBOHYDRATE POLYMERS

Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma

(2017) Roger Stupp et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Divergent evolution of temozolomide resistance in glioblastoma stem cells is reflected in extracellular vesicles and coupled with radiosensitization

(2017) Delphine Garnier et al.   NEURO-ONCOLOGY

Tumour-associated macrophages secrete pleiotrophin to promote PTPRZ1 signalling in glioblastoma stem cells for tumour growth

(2017) Yu Shi et al.   Nature Communications

The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary

(2016) David N. Louis et al.   ACTA NEUROPATHOLOGICA

Overcoming the blood–brain tumor barrier for effective glioblastoma treatment

(2015) O. van Tellingen et al.   DRUG RESISTANCE UPDATES

Glioblastoma-derived Macrophage Colony-stimulating Factor (MCSF) Induces Microglial Release of Insulin-like Growth Factor-binding Protein 1 (IGFBP1) to Promote Angiogenesis

(2015) Mamatha Bangalore Nijaguna et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma

(2014) A. P. Patel et al.   SCIENCE

featureCounts: an efficient general purpose program for assigning sequence reads to genomic features

(2013) Y. Liao et al.   BIOINFORMATICS

Oligodendrocyte Progenitor Cells Promote Neovascularization in Glioma by Disrupting the Blood-Brain Barrier

(2013) Y. Huang et al.   CANCER RESEARCH

Standards of care for treatment of recurrent glioblastoma—are we there yet?

(2012) Michael Weller et al.   NEURO-ONCOLOGY

clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters

(2012) Guangchuang Yu et al.   OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY

An Integrated Genomic Analysis of Human Glioblastoma Multiforme

(2008) D. W. Parsons et al.   SCIENCE